Cosm Medical Enters Licensing and Collaboration Agreement to Advance Personalized Gynethotics™ Devices for Post-Surgical Pelvic Recovery
Cosm Medical Corp. has announced a new licensing and collaboration agreement with Duke Health and Mayo Clinic aimed at developing and commercializing a new generation of personalized medical devices for post-surgical pelvic care. The partnership represents a significant step forward in the growing field of precision medicine and highlights increasing interest in customized solutions designed to improve recovery and quality of life for patients undergoing pelvic reconstructive surgery.
Under the terms of the agreement, Cosm Medical has licensed intellectual property from both Duke Health and Mayo Clinic involving a novel device design and its clinical use following pelvic reconstructive procedures. The collaboration will focus on advancing product evaluation, conducting clinical validation studies, and supporting the eventual commercialization of personalized recovery devices intended to aid tissue healing, improve anatomical outcomes, and provide greater comfort during post-surgical recovery.
The initiative expands Cosm Medical’s broader vision of introducing precision-based approaches into gynecological healthcare through the use of personalized medical technologies. The company specializes in the development of customized gynecological devices that combine digital imaging, advanced software, and 3D-printing technologies to create patient-specific solutions tailored to individual anatomy.
The newly announced product line, known as Gynethotics™ Recovery, is expected to build upon the company’s existing digital gynecology platform. According to Cosm Medical, the technology integrates medical imaging with advanced manufacturing techniques to produce personalized biocompatible devices designed specifically for individual patients. The company believes the approach could help address limitations associated with conventional “one-size-fits-all” devices commonly used in pelvic care today.
Pelvic reconstructive surgery is frequently performed to address conditions such as pelvic organ prolapse, urinary incontinence, and other pelvic floor disorders that can significantly impact quality of life. While surgery can improve symptoms and restore anatomical support, post-operative recovery remains a critical phase in achieving successful long-term outcomes. Clinicians continue to explore methods that may enhance healing, improve tissue remodeling, reduce discomfort, and lower the risk of complications or recurrence.
Traditional post-surgical devices and support systems used in pelvic health have historically relied on standardized designs that may not fully account for anatomical differences between patients. Researchers and clinicians increasingly recognize that variability in pelvic anatomy can influence surgical outcomes, patient comfort, and device effectiveness. Personalized medical devices are therefore emerging as a potential solution for delivering more targeted and individualized support during recovery.
Cosm Medical’s Gynethotics™ Recovery platform seeks to address this unmet need by introducing patient-specific recovery devices designed through digital modeling and additive manufacturing techniques. The company believes the approach may support a broader transition toward precision-based pelvic healthcare, where treatments and medical devices are customized according to the unique anatomical characteristics of each patient.
Derek Sham, Founder and Chief Executive Officer of Cosm Medical, described personalization as the next major frontier in pelvic health innovation. According to Sham, precision-based approaches could unlock entirely new clinical applications for gynecological medical devices and help modernize standards of care in women’s health.
He explained that the company’s goal is to help bring gynecological care closer to other medical specialties such as orthopaedics and dentistry, where custom-fabricated devices have already become widely accepted and integrated into routine patient care. In those fields, individualized implants, braces, aligners, and prosthetics are commonly used to improve precision, fit, functionality, and treatment outcomes.
Sham stated that by combining the clinical expertise of leading healthcare institutions with Cosm Medical’s scalable digital precision-care platform, the collaboration could potentially redefine how patients recover following pelvic surgery. He also emphasized the company’s belief that personalized recovery devices may improve both physical healing outcomes and overall patient experience on a global scale.
The partnership reflects a broader movement within healthcare toward precision medicine, an approach that tailors treatment strategies according to the unique biological, anatomical, and clinical characteristics of individual patients. Advances in medical imaging, digital modeling, biomaterials, and 3D printing have accelerated the development of customized healthcare solutions across multiple therapeutic areas.
In recent years, personalized devices have gained increasing traction in fields such as orthopaedics, dentistry, cardiology, and craniofacial surgery. Healthcare innovators are now exploring how similar technologies can be applied to women’s health and pelvic medicine, areas where personalized approaches have historically been less common despite significant anatomical diversity among patients.
Cassandra Kisby, Assistant Professor of Obstetrics and Gynecology at Duke University School of Medicine, highlighted the potential importance of tissue remodeling and individualized support during surgical recovery. She noted that personalized recovery devices may play a meaningful role in improving both surgical outcomes and the overall patient experience.
According to Kisby, moving away from traditional one-size-fits-all practices and toward evidence-driven personalized care represents a major evolution in the field of pelvic surgery and recovery. She suggested that individualized approaches may help clinicians better address patient-specific needs while supporting more precise post-operative healing.
The collaboration between Cosm Medical, Duke Health, and Mayo Clinic will likely involve clinical research efforts aimed at evaluating device performance, patient comfort, tissue healing outcomes, and long-term effectiveness. Clinical validation is expected to be a critical component of the development process as the organizations work to establish scientific evidence supporting the use of personalized recovery devices in pelvic reconstructive care.
The announcement also highlights the increasing role of academic medical institutions in advancing medical device innovation through partnerships with healthcare technology companies. Collaborations between industry and research hospitals are becoming increasingly important for translating emerging technologies into clinically validated products that can be integrated into routine patient care.
As women’s health receives greater attention within the medical technology sector, companies and healthcare providers are investing more heavily in solutions aimed at addressing longstanding gaps in gynecological and pelvic care. Many experts believe that innovations involving digital health, biomaterials, regenerative medicine, and personalized devices could significantly reshape the future of pelvic healthcare over the coming decade.
Cosm Medical’s precision-focused approach aligns with growing demand for minimally invasive, patient-centered technologies that improve outcomes while enhancing comfort and quality of life. By leveraging imaging data and 3D-printing technologies, the company aims to create devices that better conform to patient anatomy and provide more individualized therapeutic support.
The collaboration with Duke Health and Mayo Clinic may also contribute to broader adoption of personalized gynecological devices by generating clinical evidence and increasing awareness among surgeons and healthcare providers. If successful, the initiative could help establish new standards for post-surgical pelvic recovery and demonstrate the value of precision medicine approaches in women’s health.
As healthcare systems increasingly prioritize personalized treatment strategies and outcome-based care, innovations such as Gynethotics™ Recovery may represent an important advancement in the evolution of pelvic reconstructive medicine. Through the integration of clinical expertise, advanced manufacturing, and digital healthcare technologies, the partnership seeks to create more individualized recovery solutions capable of improving both surgical healing and patient quality of life.
About Cosm Medical
Cosm Medical Corp. (www.cosm.care) is a Toronto-based medical technology company pioneering precision pelvic care through its digital gynecology platform, enabling the fabrication of personalized gynecological devices (Gynethotics™) for conditions such as pelvic organ prolapse, incontinence, and post-surgical recovery. Cosm’s mission is to bring personalized care to women’s pelvic health.
